Glatect (glatiramer acetate)

pCPA File Number: 20985

Negotiation Status:

Concluded with an LOI

Indication(s):

Multiple Sclerosis, Relapsing-Remitting

Sponsor/Manufacturer:

Pendopharm, a division of Pharmascience Inc.

CDA-AMC Project Number:

SE0510-000

pCPA Engagement Letter Issued:

2017-09-08

Negotiation Process Concluded:

2018-03-01